Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Res ; 38(3): 1317-1325, 2018 03.
Article in English | MEDLINE | ID: mdl-29491055

ABSTRACT

BACKGROUND/AIM: Head and neck squamous cell carcinomas (HNSCCs) form a heterogeneous tumor entity located throughout the oral cavity, pharynx and larynx that is caused predominantly by chemically or virally induced carcinogenesis. Heterozygous germline mutations in cancer susceptibility genes might also lead to increased incidence of HNSCCs. As DNA stability is typically impaired in HNSCC cells and genes of the Fanconi anemia/BRCA DNA repair pathway can be mutated or down-regulated in HNSCCs, we investigated here whether germline mutations occur in the X-chromosomal FANCB as candidate gene. MATERIALS AND METHODS: Germline DNA of 85 consecutive HNSCC patients was sequenced. Missense alterations in FANCB were functionally tested in reference cells. RESULTS AND CONCLUSION: Four single nucleotide polymorphisms were identified, three of which were located in untranslated regions of FANCB (rs2188383, rs2375729, rs2905223) and predicted to be associated with normal function. One missense alteration, c.1004G>A resulting in p.G335E (rs41309679), in exon 4 was detected in five men in homozygous and in five women in heterozygous state. Four in silico prediction programs uniformally predicted p.G335E to be associated with loss-of-function of the protein. To clarify these predictions, we expressed the FANCB p.G335E protein in primary human FANCB deficient fibroblasts. Cell cycle analysis of these fibroblasts established that the FANCB p.G335E was functionally indistinguishable from the wildtype FANCB protein. Thus, functional studies in genetically defined cells showed that the p.G335E germline alteration in FANCB is not associated with impaired function.


Subject(s)
Carcinoma, Squamous Cell/genetics , Fanconi Anemia Complementation Group Proteins/genetics , Genetic Predisposition to Disease/genetics , Head and Neck Neoplasms/genetics , Mutation, Missense , Adult , Aged , Carcinoma, Squamous Cell/pathology , Cell Cycle/genetics , Female , Fibroblasts/metabolism , Gene Frequency , Genotype , Germ-Line Mutation , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide
2.
Hum Mol Genet ; 24(18): 5093-108, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26085575

ABSTRACT

Fanconi anemia (FA) is a rare inherited disorder clinically characterized by congenital malformations, progressive bone marrow failure and cancer susceptibility. At the cellular level, FA is associated with hypersensitivity to DNA-crosslinking genotoxins. Eight of 17 known FA genes assemble the FA E3 ligase complex, which catalyzes monoubiquitination of FANCD2 and is essential for replicative DNA crosslink repair. Here, we identify the first FA patient with biallelic germline mutations in the ubiquitin E2 conjugase UBE2T. Both mutations were aluY-mediated: a paternal deletion and maternal duplication of exons 2-6. These loss-of-function mutations in UBE2T induced a cellular phenotype similar to biallelic defects in early FA genes with the absence of FANCD2 monoubiquitination. The maternal duplication produced a mutant mRNA that could encode a functional protein but was degraded by nonsense-mediated mRNA decay. In the patient's hematopoietic stem cells, the maternal allele with the duplication of exons 2-6 spontaneously reverted to a wild-type allele by monoallelic recombination at the duplicated aluY repeat, thereby preventing bone marrow failure. Analysis of germline DNA of 814 normal individuals and 850 breast cancer patients for deletion or duplication of UBE2T exons 2-6 identified the deletion in only two controls, suggesting aluY-mediated recombinations within the UBE2T locus are rare and not associated with an increased breast cancer risk. Finally, a loss-of-function germline mutation in UBE2T was detected in a high-risk breast cancer patient with wild-type BRCA1/2. Cumulatively, we identified UBE2T as a bona fide FA gene (FANCT) that also may be a rare cancer susceptibility gene.


Subject(s)
Fanconi Anemia/genetics , Fanconi Anemia/metabolism , Germ Cells/metabolism , Germ-Line Mutation , Stem Cells/metabolism , Ubiquitin-Conjugating Enzymes/genetics , Adolescent , Adult , Alleles , Breast Neoplasms/genetics , Child , Child, Preschool , Chromosome Breakage , DNA Damage , Exons , Fanconi Anemia/diagnosis , Fanconi Anemia Complementation Group D2 Protein/genetics , Fanconi Anemia Complementation Group D2 Protein/metabolism , Female , Fibroblasts/metabolism , Gene Deletion , Gene Duplication , Gene Knockout Techniques , Genetic Complementation Test , Humans , Male , Middle Aged , Nonsense Mediated mRNA Decay , Phenotype , RNA, Messenger/genetics , Ubiquitin-Conjugating Enzymes/metabolism , Ubiquitination
SELECTION OF CITATIONS
SEARCH DETAIL
...